메뉴 건너뛰기




Volumn 52, Issue 11, 2012, Pages 2278-2281

Editorial: Of mad cows and bolted horses: The economics of blood safety

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD EXAMINATION; BLOOD SAFETY; DISEASE TRANSMISSION; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; PATIENT SAFETY; REVIEW; BLOOD; BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; ECONOMICS; MORTALITY; NOTE; PRION; STATISTICAL MODEL;

EID: 84869148594     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03931.x     Document Type: Review
Times cited : (5)

References (13)
  • 1
    • 84855264223 scopus 로고    scopus 로고
    • American College of Physicians Ethics Manual: Sixth edition
    • for the American College of Physicians Ethics, Professionalism, and Human Rights Committee
    • Snyder L, for the American College of Physicians Ethics, Professionalism, and Human Rights Committee. American College of Physicians Ethics Manual: sixth edition. Ann Intern Med 2012; 156: 73-104.
    • (2012) Ann Intern Med , vol.156 , pp. 73-104
    • Snyder, L.1
  • 4
    • 84869234833 scopus 로고    scopus 로고
    • Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland
    • Teljeur C, Flattery M, Harrington P, O'Neill M, Moran PS, Murphy L, Ryan M,. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland. Transfusion 2012; 52: 2281-2289.
    • (2012) Transfusion , vol.52 , pp. 2281-2289
    • Teljeur, C.1    Flattery, M.2    Harrington, P.3    O'Neill, M.4    Moran, P.S.5    Murphy, L.6    Ryan, M.7
  • 5
    • 33750314488 scopus 로고    scopus 로고
    • Managing threats rather than risks in blood transfusion: Robust design for a complex system
    • Murphy W,. Managing threats rather than risks in blood transfusion: robust design for a complex system. Transfusion 2006; 46: 2011-2013.
    • (2006) Transfusion , vol.46 , pp. 2011-2013
    • Murphy, W.1
  • 6
    • 0041412752 scopus 로고    scopus 로고
    • The value of a statistical life: A critical review of market estimates throughout the world
    • Viscusi WK, Aldy JE,. The value of a statistical life: a critical review of market estimates throughout the world. J Risk Uncertain 2003; 27: 5-76.
    • (2003) J Risk Uncertain , vol.27 , pp. 5-76
    • Viscusi, W.K.1    Aldy, J.E.2
  • 7
    • 0041807885 scopus 로고    scopus 로고
    • What is the price of life and why doesn't it increase at the rate of inflation?
    • Ubel PA, Hirth RA, Chernew ME, Fendrick AM,. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003; 163: 1637-1641.
    • (2003) Arch Intern Med , vol.163 , pp. 1637-1641
    • Ubel, P.A.1    Hirth, R.A.2    Chernew, M.E.3    Fendrick, A.M.4
  • 8
    • 46949100710 scopus 로고    scopus 로고
    • Assessing cost-effectiveness in healthcare: History of the $50,000 per QALY threshold
    • Grosse SD,. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008; 8: 165-178.
    • (2008) Expert Rev Pharmacoecon Outcomes Res , vol.8 , pp. 165-178
    • Grosse, S.D.1
  • 10
    • 0032018136 scopus 로고    scopus 로고
    • Guidelines on the clinical use of leucocyte-depleted blood components. British Committee on Standards in Haematology. Blood Transfusion Task Force
    • Guidelines on the clinical use of leucocyte-depleted blood components. British Committee on Standards in Haematology. Blood Transfusion Task Force. Transfus Med 1998; 8: 59-71.
    • (1998) Transfus Med , vol.8 , pp. 59-71
  • 11
    • 84870736699 scopus 로고    scopus 로고
    • European Union
    • European Union. EU Optimal Blood Use Project 2012. [cited 2012 Sep 1]. Available from: URL: http://www.optimalblooduse.eu
    • (2012) EU Optimal Blood Use Project
  • 12
    • 3342902745 scopus 로고    scopus 로고
    • Comparison of demographic and donation profiles and transfusion- transmissible disease markers and risk rates in previously transfused and nontransfused blood donors
    • Retrovirus Epidemiology Donor Study
    • Wang B, Higgins MJ, Kleinman S, Schreiber GB, Murphy EL, Glynn SA, Wright DJ, Nass CC, Chang D, Busch MP,; Retrovirus Epidemiology Donor Study. Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors. Transfusion 2004; 44: 1243-1251.
    • (2004) Transfusion , vol.44 , pp. 1243-1251
    • Wang, B.1    Higgins, M.J.2    Kleinman, S.3    Schreiber, G.B.4    Murphy, E.L.5    Glynn, S.A.6    Wright, D.J.7    Nass, C.C.8    Chang, D.9    Busch, M.P.10
  • 13
    • 34547624349 scopus 로고    scopus 로고
    • Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?
    • Clarke P, Will RG, Ghani AC,. Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? J R Soc Interface 2007; 4: 675-684.
    • (2007) J R Soc Interface , vol.4 , pp. 675-684
    • Clarke, P.1    Will, R.G.2    Ghani, A.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.